Request a copy

Full Text

• Akagi, T., Ono, H., Shimotohno, K., 1996. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: Possible involvement of Tax1 in the altered expression of cyclin D2, p18(ink4) and p21(Waf1/Cip1/Sdi1). Oncogene 12, 1645-1652.
• Chedid, M., Michieli, P., Lengel, C., Huppi, K., Givol, D., 1994. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Oncogene 9, 3021-3024.
• Chen, J., Jackson, P.K., Kirschner, M.W., Dutta, A., 1995. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374, 386-388.
• Dequiedt, F., Kettmann, R., Burny, A., Willems, L., 1995. Mutations in the p53 tumor-suppressor gene are frequently associated with bovine leukemia virus-induced leukemogenesis in cattle but not in sheep. Virology 209, 676-683.
• El-Diery, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., Vogelstein, B., 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
• El-Diery, W.S., Harper, J.W., O'Connor, P.M., Veculscu, V.E., Cauman, C.E., Jackman, J., Pietenpol, J.A., Burrel, M., Hill, D.E., Wang, Y., Wiman, K.G., Mercer, W.E., Kastan, M.B., Kohn, K.W., Elledge, S.J., Kinzler, K.W., Vogelstein, B., 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54, 1169-1174.
• Gao, X., Chen, Y.Q., Wu, N., Grignon, D.J., Sark, W., Porter, A.T., Honn, K.V., 1995. Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer. Oncogene 11, 1395-1398.
• Gu, Y., Turck, C.W., Margan, D.O., 1992. Inhibition of CDK2 activity in vivo by an associated 20 K regulatory subunit. Nature 366, 707-710.
• Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., Elledge, S.J., 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
• Hollstein, M., Sibdransky, D., Vogelstein, B., Harris, C.C., 1991. P53 mutations in human cancers. Science 253, 49-53.
• Hunter, T., Pines, J., 1994. Cyclins and Cancer: II. cyclin D and CDKs inhibitors come of age. Cell 79, 573-582.
• Jego, N., Thomas, G., Hamelin, R., 1993. Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. Oncogene 8, 209-213.
• Kettmann, R., Cleuter, Y. Gregoire, D., Burny, A., 1985. Role of the 3′ long open reading frame region of bovine leukemia virus in maintenance of cell transformation. J. Virol. 54, 899-901.
• Kettmann, R., Burny, A., Callebaut, I., Droogmans, L., Mammerickx, M., Willems, L., Portetelle, D., 1994. In: Levy (Ed.), The Retroviridae. Plenum, New York, pp. 39-81.
• Koopmann, J., Maintz, D., Schild, S., Schramm, J., Louis, D.N., Wiestler, O.D., Vondeimling, A., 1995. Multiple polymorphisms, but no mutations in the WAF1/CIP1 gene in human brain tumors. Br. J. Cancer. 72, 1230-1233.
• Lin, J.Y., Reichner, C., Wu, X.W., Levine, A.J., 1996. Analysis of wild-type and mutant p21(WAF-1) gene activities. Mol. Cell. Biol. 16, 1786-1793.
• Malkowicz, S.B., Tomaszewski, J.E., Linnenbach, A.J., Cangiano, T.A., Maruta, Y., McGarvey, T.W., 1996. Novel p21(WAF1/CIP1) mutations in superficial and invasive transitional cell carcinomas. Oncogene 13, 1831-1837.
• Mirsky, M.L., Olmstead, C.A., Da, Y., Lewin, H.A., 1996. The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection. J. Virol. 70, 2178-2183.
• Nakanishi, M., Robetorye R.S., Adami, G.R., Pereira-Smith, O.M., Smith, J.R., 1995. Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIp1/WAF1. EMBO J. 14, 555-563.
• Saad, F.A., Vitiello, L., Oliviero, S., Mostacciuolo, M.L., Danieli, G.A., 1993. Detection of unknown gene mutations by multiplex single-strand conformation polymorphism (MSSCP). PCR Meth. Appl. 3, 60-62.
• Sambrook, J., Fristch, E.F., Maniatis, T., 1989. Molecular cloning: A laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
• Shimizu, T., Miwa, W., Nakamori, S., Ishikawa, O., Konishi, Y., Sekiya, T., 1996. Absence of a mutation of the p21-WAF1 gene in human lung and pancreatic cancers. Jpn. J. Cancer Res. 87, 275-278.
• Van der Maaten, M., Miller, J., 1976. Replication of bovine leukemia virus in monolayer cell culture. Bibl. Haematol. 43, 360-362.
• Vogelstein, B., Kinzler, K.W., 1992. p53 function and dysfunction. Cell 70, 523-526.
• Waga, S., Hannon, G.J., Beach, D., Stillman, B., 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interacting with PCNA. Nature 369, 574-578.
• Yang, Z.Y., Perkins, N.D., Ohno, T., Nabel, E.G., Nabel, G.J., 1995. The p21 cyclin-dependent kinases inhibitor suppresses tumorigenicity in vivo. Nature Medicine 10, 1052-1056.
• Zakut, R., Givol, D., 1995. The tumor-suppression function of p21(WAF) is contained in its N-terminal half ('half-WAF'). Oncogene 11, 393-395.